Compounded products from licensed 503A pharmacies follow USP standards for sterility and potency, and provider evaluation is a routine part of legitimate access to any compounded injection
These include- Aged over 75 Decreased stomach acid Frequent use of antacids Autoimmune conditions affecting the stomach High doses of folic acid Stomach surgery Prolonged use of metformin Adoption of a vegan or vegetarian diet Excessive alcohol consumption How Does Vitamin B12 Benefit Your Body
Key Takeaways Vitamin B12 plays a major role in red blood cell health and nervous system function
I have had very high Ferritin levels for the past eighteen months (now 715) with a Tsat of 59% and
Long acting contraceptives Some women find that their periods stop if they use long term contraceptive options such as an intrauterine device or long-acting progesterone injection
Thus, there is a critical need for more effective pharmacological interventions that improve long-term management of obesity and its comorbidities.[11] Recently, nicotinamide-N-methyltransferase (NNMT) has emerged as a novel mechanism-of-action target in the adipose tissue to treat obesity and associated T2D.[1215] NNMT is a cytosolic enzyme with a newly identified role in modulating cellular energy homeostasis by jointly regulating nicotinamide (NA) and S-(5-adenosyl)-L-methionine (SAM) flux within the critical intracellular nicotinamide adenine dinucleotide (NAD + ) salvage pathway and methionine cycle, respectively.[15] NNMT expression is upregulated in the white adipose tissue (WAT) of obese and diabetic mice[12] and has significantly higher activity in the WAT compared to its activity in the brown adipose tissue, liver, and lungs of diet-induced obese mice.[16] Furthermore, plasma levels of the NNMT reaction product 1-methylnicotinamide (1-MNA) correlate with adipose NNMT expression, individuals body mass index (BMI), and waist circumference, suggesting the target to be clinically relevant.[13, 14] Importantly, mice fed a high-fat diet and treated with antisense oligonucleotides (ASOs) that reduced adipose NNMT expression were protected from diet-induced obesity (DIO) and showed reduced adiposity compared to control animals.[12] Using structure-guided design and binding calculations, we recently generated potent small molecule NNMT inhibitors around a methylquinolinium (MQ)-scaffold.[17] In the present study, we extend these findings to show that the small molecule NNMT inhibitors are highly membrane-permeable, selective inhibitors, which reduce intracellular 1-MNA levels and prevent lipogenesis in vitro
